Straumann BLT Implants

SLA surface

BLT SLA Bone Level Tapered Implants

The Bone Level Tapered Implant (BLT) is a Bone Level Implant suitable for implant treatments at bone level in combination with transmucosal or submucosal healing. The rough implant surface extends to the top of the implant and the microgap shifted inwards away from the bone.
SLA  surface
The Straumann® SLA® surface is one of the most documented rough
surfaces in implantology. The SLA® surface is produced using a technique that generates a macro-roughness on the implant surface followed by etching that superposes a micro-roughness. The resulting
topography offers an ideal structure for cell attachment.

The longevity of Straumann implants with the SLA® surface has been demonstrated in a long-term study. The following outstanding 10-year results on the SLA® surface were shown⁷,⁸:

.Unchanged survival rate: in the examined 23 patients, no im-plants were lost between years 5 and 10
.No statistically significant bone loss occurred between 5 and 10 years
.Prosthesis survival of 96 %
.No signs of peri-implantitis were noted at 10 years
.Patient satisfaction was high

8 mm
10 mm
12 mm
14 mm
16 mm
18 mm

Straumann BLT Implants
SLActive surface

BLT SLAC Bone Level Tapered Implants

The Bone Level Tapered Implant (BLT) is a Bone Level Implant suitable for implant treatments at bone level in combination with transmucosal or submucosal healing. The rough implant surface extends to the top of the implant and the microgap shifted inwards away from the bone.

SLActive® surface
The Straumann® SLActive® surface is based on the scientifically proven
SLA® topography.

In addition, it has a fundamentally improved hydrophilic surface chem-istry. SLActive® significantly accelerates the osseointegra tion process in the early healing phase (weeks 2-4) and delivers everything you expect from a successful and patient-friendly implant treatment.

Benefits:
.Safer and faster treatment in 3-4 weeks for all indications¹⁰⁻¹⁹
.Reduced healing times from 6-8 weeks down to 3-4 weeks¹⁵,¹⁹⁻²³
.Increased treatment predictability in critical protocols²⁴

Most early implant failures occur in the critical healing period between weeks 2 and 4 after implant placement¹⁷. Although similar healing patterns were observed for both SLA® and SLActive® Implants, bone-to-implant contact (BIC) was greater after 2 weeks and significantly greater after 4 weeks for SLActive® (p-value < 0.05)¹⁶. With the chemically active and hydrophilic SLActive® surface Straumann has established a new standard in oral implantology.